Endophthalmitis: Microbiology and Organism Identification Using Current and Emerging Techniques.


Journal

Ocular immunology and inflammation
ISSN: 1744-5078
Titre abrégé: Ocul Immunol Inflamm
Pays: England
ID NLM: 9312169

Informations de publication

Date de publication:
Feb 2023
Historique:
pubmed: 25 2 2022
medline: 22 2 2023
entrez: 24 2 2022
Statut: ppublish

Résumé

Endophthalmitis is an ophthalmological emergency requiring timely and appropriate diagnosis and treatment. Microbiological methods of microscopy (Gram's staining) and culture are the current gold standard for organism identification. However, a significant proportion of endophthalmitis remains culture-negative-perhaps the inflammation is non-infectious in origin, results from a novel organism are unidentifiable or because the causative organism is non-culturable often due to pre-treatment with antibiotics. This review outlines the microbiological profile of endophthalmitis, current clinically used methods for organism identification, and the newer molecular techniques of polymerase chain reaction (PCR) and next-generation sequencing (NGS) technology as diagnostic tools for endophthalmitis. They offer the potential to improve organism identification rates and clinical outcomes in infectious diseases, representing an exciting future direction for organism identification in endophthalmitis. Based on the largest ophthalmic hospital in Australia, we highlight the key practical challenges faced by Australian diagnostic laboratories for their use in a clinical setting.

Identifiants

pubmed: 35201917
doi: 10.1080/09273948.2022.2027468
doi:

Substances chimiques

DNA, Bacterial 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

393-401

Auteurs

Christine L Tan (CL)

Macular Research Unit, Centre for Eye Research Australia, East Melbourne, Australia.
Department of Ophthalmology, The University of Melbourne, Parkville, Australia.

Harsha Sheorey (H)

Department of Microbiology, St Vincent's Hospital, Fitzroy, Australia.

Penelope J Allen (PJ)

Macular Research Unit, Centre for Eye Research Australia, East Melbourne, Australia.
Department of Ophthalmology, The University of Melbourne, Parkville, Australia.
Vitreo-retinal Unit, The Royal Victorian Eye and Ear Hospital, East Melbourne, Australia.

Rosie C H Dawkins (RCH)

Macular Research Unit, Centre for Eye Research Australia, East Melbourne, Australia.
Department of Ophthalmology, The University of Melbourne, Parkville, Australia.
Vitreo-retinal Unit, The Royal Victorian Eye and Ear Hospital, East Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH